Published on
December 13, 2023
- 14:43 GMT
Human medicines European public assessment report (EPAR): Jesduvroq, daprodustat, Status: Withdrawn application
Jesduvroq was developed as a medicine to treat the symptoms of anaemia (low red blood cell counts) caused by chronic kidney disease (long-term, progressive decrease in the ability of the kidneys to work properly). It was intended for adult patients on …
Distribution channels:
Healthcare & Pharmaceuticals Industry
